ALKS Alkermes Plc

$30.65

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/2/2025

About Alkermes Plc

Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.

Website: https://www.alkermes.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1520262
Address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IE
Valuation
Market Cap
$4.45B
P/E Ratio
12.27
PEG Ratio
-1057.29
Price to Book
3.04
Performance
EPS
$2.20
Dividend Yield
Profit Margin
23.60%
ROE
27.90%
Technicals
50D MA
$32.85
200D MA
$29.28
52W High
$36.45
52W Low
$22.90
Fundamentals
Shares Outstanding
165M
Target Price
$39.71
Beta
0.35

ALKS EPS Estimates vs Actual

Estimated
Actual

ALKS News & Sentiment

Sep 29, 2025 • Benzinga BULLISH
Agiloft and Spaulding Ridge Partner to Transform Contracting for CFOs and Global Enterprises
Strategic alliance to deliver enterprise-ready CLM transformation services to agility, compliance, and growth REDWOOD CITY, Calif., Sept. 29, 2025 /PRNewswire/ -- Agiloft, a leader in data-first contract lifecycle management ( CLM ) , today announced a strategic partnership with Spaulding Ridge, ...
Sep 26, 2025 • Benzinga SOMEWHAT-BULLISH
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Ciena ( NYSE:CIEN ) , Alkermes ( NASDAQ:ALKS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Sep 16, 2025 • Benzinga SOMEWHAT-BULLISH
Global Psychotic Disorders Market Poised For Significant Growth
The global market for medications addressing psychotic disorders is projected to reach $32.1 billion by 2033, exhibiting a robust compound annual growth rate ( CAGR ) of 6.5% over the forecast period.
Sep 10, 2025 • Zacks Commentary NEUTRAL
Immunovant ( IMVT ) Up 7.8% Since Last Earnings Report: Can It Continue?
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sep 03, 2025 • Zacks Commentary NEUTRAL
Krystal Biotech ( KRYS ) Up 8.5% Since Last Earnings Report: Can It Continue?
Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sep 03, 2025 • Benzinga SOMEWHAT-BULLISH
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Cogent Biosciences ( NASDAQ:COGT ) , Alkermes ( NASDAQ:ALKS )
U.S. stocks were mixed, with the Dow Jones index falling over 150 points on Wednesday. Shares of Macy's, Inc. M rose sharply during Wednesday's session after the company reported second-quarter results above estimates and raised its FY2025 guidance.
Sentiment Snapshot

Average Sentiment Score:

0.145
50 articles with scored sentiment

Overall Sentiment:

Neutral

ALKS Reported Earnings

Apr 29, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.29 Surprise
  • Reported EPS: $1.05
  • Estimate: $0.76
  • Whisper:
  • Surprise %: 37.6%
Oct 24, 2024
Sep 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.72
  • Estimate: $0.74
  • Whisper:
  • Surprise %: -2.7%
Jul 24, 2024
Jun 30, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.70
  • Estimate: $0.70
  • Whisper:
  • Surprise %: 0.0%
May 01, 2024
Mar 31, 2024 (Pre market)
-0.15 Surprise
  • Reported EPS: $0.43
  • Estimate: $0.58
  • Whisper:
  • Surprise %: -25.9%
Feb 15, 2024
Dec 31, 2023 (Pre market)
-0.29 Surprise
  • Reported EPS: $0.22
  • Estimate: $0.51
  • Whisper:
  • Surprise %: -56.9%
Oct 25, 2023
Sep 30, 2023 (Pre market)
0.2 Surprise
  • Reported EPS: $0.64
  • Estimate: $0.44
  • Whisper:
  • Surprise %: 45.5%
Jul 26, 2023
Jun 30, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.46
  • Whisper:
  • Surprise %: 19.6%
Apr 26, 2023
Mar 31, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.01
  • Whisper:
  • Surprise %: 200.0%

Financials